Neurol. praxi. 2008;9(3):179-181

První zkušenosti s kontinuální dopaminergní stimulací u pokročilé Parkinsonovy choroby

MUDr. Martin Vališ2, MUDr. Radomír Taláb, CSc.1, doc. MUDr. Gerhard Waberžinek, CSc.2, MUDr. Petr Štěpán, Martina Mulačová3
1 Neurologická klinika FN, Hradec Králové
2 Neurologická klinika LF UK a FN v Hradci Králové
3 LF UK, Hradec Králové

Kazuistika 79letého muže s pokročilou Parkinsonovou chorobou ve stadiu pozdních hybných komplikací, u kterého byla poprvé v České republice úspěšně zahájena kontinuální dopaminergní stimulace Duodopou po selhání klasické farmakoterapie.

Keywords: pokročilá Parkinsonova choroba, motorické komplikace, kontinuální dopaminergní stimulace – Duodopa

Published: July 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vališ M, Taláb R, Waberžinek G, Štěpán P, Mulačová M. První zkušenosti s kontinuální dopaminergní stimulací u pokročilé Parkinsonovy choroby. Neurol. praxi. 2008;9(3):179-181.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001; 16: 448-458. Go to original source... Go to PubMed...
    2. Antonini A. Continuous dopaminergic stimulation-From theory to clinical practice. Parkinsonism Relat Disord 2007; 13: 24-28. Go to original source... Go to PubMed...
    3. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body patology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002; 249 (Suppl. 3): 1301-1304. Go to original source... Go to PubMed...
    4. Deleu D, Hanssens Y, Northway MG. Subcutaneus apomorphine: an evidence-based review of its use in Parkinson´s disease. Drugs Aging 2004; 21: 973-981. Go to original source...
    5. Hariz MI. Complication of deep brain stimulation surgery. Mov Disord 2002; 17(Suppl 3): S162-S166. Go to original source... Go to PubMed...
    6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184. Go to original source... Go to PubMed...
    7. Jankovic J. An update on the treatment of Parkinson's disease. Mt Sinai J Med 2006; 73: 682-689.
    8. Kanovsky P, Kubova D, Bares M, Hortova H, Streitova H, Rektor I, et al. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of two-year, prospective follow-up. Mov Disord 2002; 17: 188-191. Go to original source... Go to PubMed...
    9. Nilsson D, Nyholm D, Aquilonius SM. Duodenal levodopa infusion in Parkinson's disease - long-term experience. Acta Neurol Scand 2001; 104: 343-348. Go to original source... Go to PubMed...
    10. Nutt JG, Holford NHG. The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 1996; 39: 561-573. Go to original source... Go to PubMed...
    11. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, et al. Duodenal levodopa infusion monotherapy vs. oral polypharmacy in advanced Parkinson disease. Neurology 2005; 64: 216-223. Go to original source... Go to PubMed...
    12. Obeso JA, Rodriguez-Oroz M, Marin C, et al. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 2004; 62: 17-30. Go to original source... Go to PubMed...
    13. Rektorová I, Rektor I. Parkinsonský syndrom. In: Rektor I, Rektorová I, et al. Centrální poruchy hybnosti v praxi. Movement disorders. Praha: Triton 2003; 21-70.
    14. Stocchi F, Olanow CW. Continuous dopaminergic stimulation in early and advanced Parkinson's disease. Neurology 2004; 62: 56-63. Go to original source... Go to PubMed...
    15. Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265-272. Go to original source... Go to PubMed...
    16. Westin J, Nyholm D, Groth T, Dougherty MS, Yerramsetty PK, Palhagen SE: Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease. Parkinsonism Relat Disord 2006; 12: 509-513. Go to original source... Go to PubMed...
    17. Wolters CHE. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 18-23. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.